APA (7th ed.) Citation

Yang, M., Li, C., Li, Y., Cheng, C., Shi, M., Yin, L., . . . Liu, Y. Design, synthesis, biological evaluation and molecular docking study of 2,4-diarylimidazoles and 2,4-bis(benzyloxy)-5-arylpyrimidines as novel HSP90 N-terminal inhibitors. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Yang, Man, Chenyao Li, Yajing Li, Chen Cheng, Meiyun Shi, Lei Yin, Hongyu Xue, and Yajun Liu. Design, Synthesis, Biological Evaluation and Molecular Docking Study of 2,4-diarylimidazoles and 2,4-bis(benzyloxy)-5-arylpyrimidines as Novel HSP90 N-terminal Inhibitors. Taylor & Francis Group.

MLA (9th ed.) Citation

Yang, Man, et al. Design, Synthesis, Biological Evaluation and Molecular Docking Study of 2,4-diarylimidazoles and 2,4-bis(benzyloxy)-5-arylpyrimidines as Novel HSP90 N-terminal Inhibitors. Taylor & Francis Group.